Captain & Commander go on a road trip for Famotidine
Camber Pharma Launches Generic Pepcid®
Famotidine Tablets are indicated in adult and pediatric patients 88lb and greater for the treatment of:
– active duodenal ulcer (DU)
– active gastric ulcer (GU)
– symptomatic nonerosive gastroesophageal reflux disease (GERD)
Famotidine Tablets are indicated in adults for the:
– treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).
– reduction of the risk of duodenal ulcer recurrence
Famotidine Tablets from Camber are available in 20 mg 100 and 1000 count bottles and 40 mg 100, 500 and 1000 count bottles. Click here to learn more about Famotidine.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection